(−)−Epigallocatechin‐3‐gallate Inhibits Pancreatic Lipase and Reduces Body Weight Gain in High Fat‐Fed Obese Mice

Citations Over TimeTop 10% of 2011 papers

Abstract

Tea (Camellia sinensis, Theaceae) has been shown to have obesity preventive effects in laboratory studies. We hypothesized that dietary epigallocatechin-3-gallate (EGCG) could reverse metabolic syndrome in high fat-fed obese C57bl/6J mice, and that these effects were related to inhibition of pancreatic lipase (PL). Following treatment with 0.32% EGCG for 6 weeks, a 44% decrease in body weight (BW) gain in high fat-fed, obese mice (P < 0.01) was observed compared to controls. EGCG treatment increased fecal lipid content by 29.4% (P < 0.05) compared to high fat-fed control, whereas in vitro, EGCG dose-dependently inhibited PL (IC(50) = 7.5 µmol/l) in a noncompetitive manner with respect to substrate concentration. (-)-Epicatechin-3-gallate exhibited similar inhibitory activity, whereas the nonester-containing (-)-epigallocatechin did not. In conclusion, EGCG supplementation reduced final BW and BW gain in obese mice, and some of these effects may be due to inhibition of PL by EGCG.

Related Papers

• → Improvement of catalytic activity and stability of lipase by immobilization on organobentonite(2011)68 cited
• → Extracellular lipase production by Yarrowia lipolytica under magnetic fields(2023)7 cited
• Study on Lipase Modified with Tween(2005)
• Screening of lipase producing strains and studing on properties of lipase(2008)
• Editorial Note on Journal of Nutrition and Weight Loss (2020)(2020)